GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (OSL:TRMED) » Definitions » Cash Flow from Financing

Thor Medical ASA (OSL:TRMED) Cash Flow from Financing : kr104.10 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2024, Thor Medical ASA received kr114.10 Mil more from issuing new shares than it paid to buy back shares. It received kr0.00 Mil from issuing more debt. It paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received kr0.00 Mil from paying cash dividends to shareholders. It spent kr10.30 Mil on other financial activities. In all, Thor Medical ASA earned kr103.80 Mil on financial activities for the six months ended in Dec. 2024.


Thor Medical ASA Cash Flow from Financing Historical Data

The historical data trend for Thor Medical ASA's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thor Medical ASA Cash Flow from Financing Chart

Thor Medical ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.46 385.10 228.13 -0.33 104.04

Thor Medical ASA Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.28 -0.20 -0.20 0.30 103.80

Thor Medical ASA Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Thor Medical ASA's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Thor Medical ASA's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr104.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thor Medical ASA  (OSL:TRMED) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Thor Medical ASA's issuance of stock for the six months ended in Dec. 2024 was kr114.10 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Thor Medical ASA's repurchase of stock for the six months ended in Dec. 2024 was kr0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Thor Medical ASA's net issuance of debt for the six months ended in Dec. 2024 was kr0.00 Mil. Thor Medical ASA received kr0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Thor Medical ASA's net issuance of preferred for the six months ended in Dec. 2024 was kr0.00 Mil. Thor Medical ASA paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Thor Medical ASA's cash flow for dividends for the six months ended in Dec. 2024 was kr0.00 Mil. Thor Medical ASA received kr0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Thor Medical ASA's other financing for the six months ended in Dec. 2024 was kr-10.30 Mil. Thor Medical ASA spent kr10.30 Mil on other financial activities.


Thor Medical ASA Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Thor Medical ASA Business Description

Traded in Other Exchanges
Address
Karenslyst Alle 9C, Oslo, NOR, 0278
Thor Medical ASA is a company engaged in producing and supplying of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232). The objective of the company is to supply alpha emitters to suppliers and developers of innovative drugs targeting indications of high unmet medical need, including any medical products and equipment, and to run business related thereto or associated therewith.

Thor Medical ASA Headlines

No Headlines